SCHEMBL23427301

SCHEMBL23427301

N#Cc1c2ccccc2c(-c2cccc3oc4cc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)ccc4c23)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.39
▸ ALDH1A1 P00352 6/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ PDE9A O76083 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ TNKS O95271 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ PIM1 P11309 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ FGFR1 P11362 1/20 0.31
▸ FGFR2 P21802 1/20 0.31
▸ FGFR4 P22455 1/20 0.31
▸ FGFR3 P22607 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ HPGD P15428 3/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ SQOR Q9Y6N5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23427731 1.00 ADORA2A (0.39) ADORA2AALDH1A1HSD17B10ALOX15PDE9A
SCHEMBL23427224 0.96 TNKS (0.34) ADORA2AALDH1A1PDE9ATNKSKDM4E
SCHEMBL23426866 0.90 ADORA2A (0.41) ADORA2AALDH1A1HSD17B10ALOX15PDE9A
SCHEMBL23746944 0.90 AHR (0.37) ALDH1A1ATMTNKSKDM4EHPGD
SCHEMBL23427704 0.89 ESR2 (0.35) ADORA2AALDH1A1HSD17B10ATMTNKS
SCHEMBL23427335 0.89 ESR2 (0.35) ADORA2AALDH1A1HSD17B10ATMTNKS
SCHEMBL23428265 0.88 AHR (0.39) ALDH1A1TNKSKDM4EHPGDL3MBTL1
SCHEMBL23427617 0.88 MMP12 (0.36) ALDH1A1ATMTNKSKDM4EHPGD
SCHEMBL23427057 0.88 ADORA2A (0.44) ADORA2AALDH1A1HSD17B10ALOX15PDE9A
SCHEMBL23428230 0.88 MMP12 (0.36) ALDH1A1ATMTNKSKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11991927-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-21 — — US disclosed
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 — — US disclosed
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 — — US disclosed
US-20210249610-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-08-12 — — US disclosed
EP-3859812-A1 ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2021-08-04 — — EP disclosed
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210167299-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, AOX1, OXER1 ADORA2A 1421/4885ALDH1A1 76/4885HSD17B10 1231/4885
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, AOX1 ADORA2A 3764/4885ALDH1A1 43/4885HSD17B10 1370/4885
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 ADORA2A 3495/4885ALDH1A1 11/4885HSD17B10 1493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback